About this trial
The purpose of this study is to evaluate the clinical results of patients who received revascularization of the aorta and peripheral artery at Asan Medical Center.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients underwent Revascularization of Aorta or Peripheral artery from 2011 at the Peripheral Vascular Disease Center, Asan Medical Center
Aneurysm
Aortic dissection
Penetrating aortic ulcer
Disqualifiers
For prospective cohort, not agreeing to participate with written informed consent form
Trial population
Patients underwent Revascularization of Aorta or Peripheral artery from 2011 at the Peripheral Vascular Disease Center, Asan Medical Center
Trial design
Cohort
Other
Treatments tested in this trial
Treatment
Other interventionEVAR,TEVAR,PTA
Treatment groups
Trial outcomes
Primary outcomes
Rate of death from any cause
all-cause death
Rate of major Adverse Limb Events
above-ankle amputation of the index limb,major index-limb reintervention including new bypass,interposition graft revision,thrombectomy, or thrombolysis
Secondary outcomes
Rate of death from all cause including cardiovascular death
cardiovascular death,Non-cardiovascular death
Rate of stroke
Ischemic , hemorrhagic , mixed Stroke
Rate of myocardial Infarction
Spontaneous MI
Rate of vascular complication
Vascular complication
Sponsors and contacts
Click on the lead sponsor to view all of their trials.